Trial Profile
Examination of Efficacy and Safety of SERM or Bisphosphonates After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Sep 2021
Price :
$35
*
At a glance
- Drugs Bazedoxifene (Primary) ; Eldecalcitol (Primary) ; Bisphosphonates
- Indications Osteopetrosis
- Focus Therapeutic Use
- 20 Sep 2021 Planned End Date changed from 23 Nov 2025 to 23 Nov 2026.
- 20 Sep 2021 Planned primary completion date changed from 23 Nov 2022 to 23 Nov 2024.
- 03 Dec 2018 New trial record